Company / Named in our posts
Fusion Pharmaceuticals Inc..
Follow Fusion Pharmaceuticals Inc.A clinical-stage oncology company focused on developing next-generation targeted alpha therapies as precision medicines.[1]
01Deal
Deals on Carrywatch
Every deal that names Fusion Pharmaceuticals Inc., and its role in each.
Fusion Pharmaceuticals Inc. / RadioMedix
Fusion Pharmaceuticals takes on RadioMedix assets for FPI-2265
See deal detailsDeal Web
Fusion Pharmaceuticals Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Fusion Pharmaceuticals Inc. reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Fusion Pharmaceuticals to Acquire Phase 2 Program for 225 Ac-PSMA I&T, a Radiopharmaceutical Targeting Metastatic Castrate Resistant Prostate Cancer
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02Form 8-K/A
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Fusion Pharmaceuticals Inc.:
- P01